Abstract
The medial forebrain bundle (MFB) was partially lesioned with 6-hydroxydopamine (6-OHDA) in order to investigate the effect of deficient central noradrenergic regulation on thyrotropin (TSH) secretion in the rat. 6-OHDA injection into the MFB significantly reduced the noradrenaline (NA), dopamine (DA) and serotonin (5-HT) content of the whole hypothalamus. NA and 5-HT concentrations were also significantly decreased in the paraventricular nucleus (PVN). The MFB lesion did not affect the clonidine (250 μg/kg, i.p.) induced stimulation of TSH release or the isoproterenol (1 mg/kg i.p.) induced decrease in TSH levels. Thyrotropin releasing hormone (TRH, 5 μg/kg i.v.) caused a similar significant stimulation of TSH secretion in lesioned and non-lesioned rats. The present results do not support the hypothesis that the blunted TSH response to TRH observed in depressed patients results from a deficiency in noradrenergic neurotransmission.
Similar content being viewed by others
References
Loosen P. T., and Prange A. J. 1982. Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients. A review. Am J Psychiatry 139:405–416.
Roy A., Karoum F., and Linnoila P. D. 1988. Thyrotropin releasing hormone test in unipolar depressed patients and controls: Relationship to clinical and biological variables. Acta Psychiat Scand 77:151–159.
Roy A., Pickar D., and Paul S. 1984. Biologic test in depression. Psychosomatics 25:443–451.
Ettigi P. G., and Brown G. M. 1977. Psychoneuroendocrinology of affective disorder: An overview. Am J Psychiatry 134:493–501.
Jackson I. M. D. 1984. Hypothalamic releasing hormones: Mechanisms underlying neuroendocrine dysfunction in affective disorders. Pages 255–266,in Brown, G.M., Koslow, S., and Reichlin, S. (eds.), Neuroendocrinology and Psychiatric Disorder, Raven Pres, New York.
Siever L. J., and Davies K. L. 1985. Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 142:1017–1031.
Siever L. J., and Davis K. L. 1984. Dysregulation of the noradrenergic system in depression. Psychopharmacology Bulletin 20:500–504.
Morley, J. E. 1981. Neuroendocrine control of thyrotropin secretion. Endocrine Rev 2:396–434.
Tuomisto J., and Männisto P. 1985. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37:249–1738.
Jaffer A., Russell V. A., and Tajaard J. J. F. 1987. Noradrenergic and dopaminergic modulation of thyrotropin secretion in the rat. Brain Res 404:267–272.
Aizawa T., and Greer M. A. 1981. Delineation of the hypothalamic area controlling thyrotropin secretion in the rat. Endocrinology 109:1713–1738.
Krulich L., Vijayan E., Coppings R. J., Giachetti A., McCann S. M., and Mayfield M. S. 1979. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat. Endocrinology 105:276–283.
Niewenhuys R., Geeraedts L. M. G., and Veening J. G. 1982. The medial forebrain bundle of the rat. I. General introduction. J Comp Neurol 206:49–295.
Olson L., and Fuxe K. 1972. Further mapping out of noradrenaline neuron systems: Projections of the ‘subcoeruleus’ area. Brain Res 43:289–295.
Mermet C. C., and Gonon F. G. 1988. Ether stress stimulates noradrenaline release in the hypothalamic paraventricular nucleus. Neuroendocrinol 47:75–82.
Swanson L. W., Sawchenko P. E., and Lind R. W. 1986. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response. Prog in Brain Res 68:169–190.
Towell A., Muscat R., and Willner P. 1988. Noradrenergic receptor interactions in feeding elicited by stimulations of the paraventricular hypothalamus. Pharmacol Biochem & Behavior 32:133–139.
Lesch K. P., and Rupprecht R. 1989. Psychoneuroendocrine research in depression II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-end organ dysfunction. J Neural Transm 75:179–194.
Pellegrino L. J., Pellegrino A. S., and Cushman A. J. 1979. A stereotaxic atlas of the rat brain, 2nd Ed. Plenum Press, New York.
Palkovits M., and Brownstein M. J. 1988. Maps and guide to microdissection of the rat brain, 1st Ed. Elsevier, New York.
Russell V. A., Lamm M. C. L., De Villiers A. S., Taljaard J. J. F., and Chalton D. O. 1985. Effects of combined administration of L-tryptophan and tricyclic antidepressants on alpha and beta adrenoceptors and monoamine levels in the rat brain. Neurochem Res 10:1661–1671.
Terry L. C., and Martin J. B. 1981. The effects of lateral hypothalamic-medial forebrain stimulation and somatostatin antiserum on pulsatile growth hormone secretion in freely behaving rats: evidence for a dual regulatory mechanism. Endocrinology 109:622–627.
Feldman S., Conforti N., and Melamed E. 1986. Norepinephrine depletion in the paraventricular nucleus inhibits the adrenocortical responses to neural stimuli. Neurosci Lett 64:191–195.
Lookingland K. J., Chapin D. S., McKay D. W., and Moore K. E. 1986. Comparative effects of the neurotoxins N-chloroethyl-N-2-bromobenzylamine hydrochloride (DSP4) and 6-hydoxydopamine on hypothalamic noradrenergic, dopaminergic and 5-hydroxytryptaminergic neurons in the male rat. Brain Res 365:228–234.
Jaffer A., Searson A., Russell V. A., and Taljaard J. J. F. 1990. The effect of selective noradrenergic denervation on thyrotropin secretion in the rat. Neurochem Res 15:13–16.
Jonsson G., Hallmam H., Ponzio F., and Ross S. 1981. DSP4 (N(2-chloroethyl)-N-ethyl-2-bromo-benzylamine) a usefull denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 72:173–188.
Ungerstedt U. 1971. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 567:1–48.
Jaffer A., Russell V. A., and Taljaard J. J. F 1987. Effect of chronic desipramine treatment on neurotransmitter-thyrotropin releasing hormone-thyrotropin interactions in the rat. Neurochem Res 12:1013–1017.
Krulich L., Mayfield M. A., Steele M. K., McMillen B. A., McCann S. M., and Koenig J. I. 1982. Differential effects of pharmacological manipulations of central α1 and α2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology 110:796–804.
Schettini G., Quattrone A., Di Renzo G., Lombardi G., and Preziosi P. 1979. Effect of 6-hydroxy-dopamine treatment on TSH secretion in basal and cold-stimulated conditions in the rat. Eur J Pharmacol 56:153–157.
Ishikawa K., Kakegawa T., and Suzuki M. 1986. Plasma thyrotropin (TSH) response to intrahypothalamic injection of an alpha-2-adrenergic receptor agonist (clonidine). Acta Endocrinol 111:25–29.
Ishikawa K., Kakegawa T., and Suzuki M. 1984. Role of the hypothalamic paraventricular nucleus in the secretion of thyrotropin under adrenergic and cold-stimulated conditions in the rat. Endocrinology 114:352–358.
Young W. S., and Kuhar M. J. 1980. Noradrenergic α1 and α2 receptors: Light microscopic autoradiographic localization. Proc Natl Acad Sci USA 77:1696–1700.
Krieg R. J., Perkins S. N., Johnson J. H., Rogers J. P., Arimura A., and Cronin M. J. 1988. β-Adrenergic stimulation of growth hormone (GH) releasein vivo, and subsequent inhibition of GH-releasing factor-induced GH secretion. Endocrinology 122:531–537.
Ahren B., and Rerup C. 1983. Effect of beta-adrenoceptor agonists and antagonists on thyroid hormone secretion. Eur J Pharmacol 88:383–389.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jaffer, A., Daniels, W.M.U., Russell, V.A. et al. The effect of medial forebrain bundle lesion on thyrotropin secretion in the rat. Neurochem Res 16, 577–581 (1991). https://doi.org/10.1007/BF00974877
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00974877